Ionis Pharmaceuticals (IONS) Goodwill & Intangibles (2009 - 2022)

Ionis Pharmaceuticals' Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at $29.6 million for Q3 2022.

• In Q3 2022, Goodwill & Intangibles fell 1.44% year-over-year to $29.6 million; the TTM figure through Sep 2022 stood at $29.6 million (down 1.44% YoY), while the FY2021 annual figure was $29.0 million, up 3.82% from the prior year.
• Goodwill & Intangibles was $29.6 million for Q3 2022 at Ionis Pharmaceuticals, up from $29.1 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $30.0 million in Q3 2021 to a low of $22.9 million in Q1 2018.
• Historically, Goodwill & Intangibles has averaged $27.1 million across 5 years, with a median of $27.7 million in 2020.
• The sharpest annual moves came in 2019 and 2022: Goodwill & Intangibles rose 12.31% in 2019, then decreased 1.44% in 2022.
• A 5-year view of Goodwill & Intangibles shows it stood at $24.0 million in 2018, then climbed by 6.83% to $25.7 million in 2019, then grew by 8.81% to $27.9 million in 2020, then rose by 3.82% to $29.0 million in 2021, then advanced by 2.07% to $29.6 million in 2022.
• The last three Goodwill & Intangibles figures came in at $29.6 million (Q3 2022), $29.1 million (Q2 2022), and $29.3 million (Q1 2022), per Business Quant data.